Talk:Olanzapine

This is the talk page for discussing improvements to the Olanzapine article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Archives: 1: 31 days

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Olanzapine.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Pharmacology B‑class High‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
B	This article has been rated as B-class on Wikipedia's content assessment scale.
High	This article has been rated as High-importance on the project's importance scale.

Medicine: Psychiatry B‑class High‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
B	This article has been rated as B-class on Wikipedia's content assessment scale.
High	This article has been rated as High-importance on the project's importance scale.
	Psychiatry portal This article is supported by the Psychiatry task force.

Archives

/Archive 1

This page has archives. Sections older than 31 days may be automatically archived by when more than 4 sections are present.

NYT

Here's an important article that just came out in the NY Times http://www.nytimes.com/2006/12/18/business/18drug.html?hp&ex=1166504400&en=abbfa89f1f363c93&ei=5094&partner=homepage — Preceding unsigned comment added by 71.206.230.233 (talk)

NMS

Someone add Neuroleptic Malignant Syndrome to the side effects. Also, why does the Zyprexa talk page have so few entries compared to the Risperdal talk page? 78.156.109.166 (talk) 08:34, 24 October 2013 (UTC)[reply]

Zyprexa in popular culture

I added a rubric about zyprexa in popular culture like lithium and prozac have but it was deleted straightaway — Preceding unsigned comment added by 217.231.152.138 (talk) 14:49, 8 April 2014 (UTC)[reply]

It's just trivia that is not relevant to the article content and therefore inappropriate include. -- Ed (Edgar181)

Hello to anyone! And I am using olanzapine but this medicine has destroyed my whole dreams. What can I? Do you help me?--213.74.88.251 (talk) 15:01, 2 October 2014 (UTC)[reply]

Possible Vandalism by a troll

This quote is ridiculous because Olanzapine is first line in anorexia nervosa - "Evidence does not support the use of atypical antipsychotics including olanzapine in eating disorders." 182.255.99.214 (talk) 08:32, 25 February 2015 (UTC)[reply]

Ref says "For eating disorder patients specifically, evidence shows that atypicals are do not cause significant weight gain." [1] So looks fine. Here are our referencing requirements if you are interested WP:MEDRS Doc James (talk · contribs · email) 09:00, 25 February 2015 (UTC)[reply]

IP address, is there a treatment guideline you are aware of, that says this? quite often with psych drugs, all options are poor, and treatment guidelines are what guide doctors and patients through the morass. Jytdog (talk) 13:15, 25 February 2015 (UTC)[reply]

Best Practice BMJ: "Atypical antipsychotics have been used in the treatment of AN. A double-blind placebo-controlled study has shown that adult patients receiving olanzapine attain ideal body weight slightly more rapidly than those receiving placebo, with a slightly greater reduction in obsessive compulsive symptoms in the olanzapine-treated group. [82] There are very few reports of the use of olanzapine in adolescents. [82] Care should be taken to decrease and discontinue treatment when the patient is near ideal body weight. Atypical antipsychotics - particularly ziprasidone, but perhaps the other atypicals as well - can be associated with prolonged QTc interval. [83] Thus, prior to use of olanzapine, an ECG should be performed and repeated periodically during treatment."

NHS has suggested that in the UK olanzapine is second line after SSRI's, but the reality is that first presentation for AN is usually in ED, where electrolytes are rebalanced... and of course an antipsychotic is introduced (http://www.nhs.uk/Conditions/Anorexia-nervosa/Pages/Treatment.aspx) 182.255.99.214 (talk) 10:26, 11 March 2015 (UTC)[reply]